This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Friday's Small-Cap Winners & Losers

Odyssey Healthcare's (ODSY) rating was upped to buy from hold by a Deutsche Securities analyst, sending the Dallas-based company's shares up $1.17, or 9%, to $14.21.

Amcol International (ACO - Get Report) reported soaring fourth-quarter profits. Earnings for the quarter totaled $12 million, or 39 cents a share, compared with $8.4 million, or 27 cents a share, a year ago.

Excluding a tax-cut benefit of 3 cents a share, income beat estimates by 2 cents a share. Fourth-quarter revenue climbed 16% to $155.9 million from a year ago, which eclipses the $155.1 million projection. Shares were gaining $2.05, or 7.9%, to $28.70.

Enterra Energy Trust (ENT - Get Report) tumbled after the Canada-based driller halved its monthly dividend to 6 cents a share. Shares were falling $1.26, or 15.5%, to $6.88.

Pharmos (PARS) sank after the biotech announced that its proposed synthetic cannabinoid compound didn't relieve a particular model of induced pain, as compared with a placebo, in midphase testing.

The Iselin, N.J.-based company said that the compound, which is chemically related to marijuana, was nonetheless well tolerated. Shares were losing 19 cents, or 10.5%, to $1.62.

Irvine Sensors (IRSN) slid after the Costa Mesa, Calif., chipmaker said it will be late with its 2006 financials, which were due Jan. 18. The company says it will file the results "as soon as possible." Shares were down 9 cents, or 5.5%, to $1.55.

2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,634.55 -38.05 -0.22%
S&P 500 2,046.11 -5.71 -0.28%
NASDAQ 4,747.3460 -10.5330 -0.22%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs